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The peptide lactone antibiotic TL-119 and/or A-3302-B was chemically synthesized in order to confirm the proposed structure. The synthetic om- 
pound was different from both natural TL-119 and A-3302-B in their physicochemical properties and in biological activity. Re-examination of 
the configuration of the constituent amino acid residues in natural TL-119 and/or A-3302-B indicated that natural TL-I 19 and A-3302-B contains 
D-aThr instead of the original L-Thr. We tentatively propose a revised structure for TL-119 and/or A-3302-B. 
Cyclic peptide; Peptide synthesis; Antibacterial activity; Structure confirmation 
1. INTRODUCTION 
TL-119 (1) is a peptide antibiotic isolated from a 
strain of Bacillus subtilis, which is active against Gram- 
positive bacteria [ 11. Nakagawa et al. proposed a struc- 
ture (I) for TL-119 without describing the 
stereochemistry of the amino acid residues as shown in 
Fig. 1A [2]. The structure I indicates that the antibiotic 
is a peptide lactone containing an ester bond and an 
a,&dehydroamino acid, 2-amino-2-butenoic acid 
(AAba), at position 7 in the molecule. Two antibiotics, 
A-3302-A and -B, were also isolated from a strain of 
Bacillus subtilis, and their structures including the 
stereochemistry of the constituent amino acids were 
elucidated [3]. One of them, A-3302-B (2), was assum- 
ed to be identical with TL-119 based on the structural 
similarity (Fig. 1A) [3]. 
We were interested in confirming the unique struc- 
ture I proposed for TL-119 and/or A-3302-B by its 
chemical synthesis, and in studying the structure- 
activity relationship of the antibiotic by the synthesis of 
various analogs. Hereafter compound number 3 is used 
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for the compound that has the structure of I. In this 
report we describe the synthesis of I, its 
physicochemical properties and biological activity and 




Specific optical rotations were measured with a Union high- 
sensitivity polarimeter PM-71. ‘H-NMR spectra at 90 MHz were 
recorded on a Jeol JNM-FX90Q, tetramethylsilane as an internal 
standard. Mass spectra were taken on a Jeol mass spectrometer 
Model JMS-OISG-2 with a direct inlet system operating at 75 eV. IR 
spectra were recorded on a Hitachi infrared spectrophotometer 
Model 260-10. Circular dichroism (CD) spectra were taken on a Jasco 
J-600A spectropolarimeter using a cell of 0.1 cm path length. Amino 
acid analysis was performed with a Yanagimoto amino acid analyzer 
LC-EA. The modified Manning-Moore method to analyze dipeptide 
diastereoisomers was carried out with a Hitachi amino acid analyzer 
KLA-5 with spherical resin under the following conditions: column, 
0.6 x 55 cm; buffer, 0.1 M sodium citrate at pH 4.25 and 0.35 M 
sodium citrate at pH 5.28; flow rate, 30 ml/h; jacket temperature, 
55°C. 
2.2. Synthesis of 3 
The ring part (tetrapeptide lactone) of the precursor was suc- 
cessfully prepared as follows (see Fig. 2). At first an ester bond bet- 
ween the hydroxyl function in Z-L-Thr-OPac and the carboxyl 
function in Boc-L-Thr(Bzl)-OH was formed by the 
DCC/4-dimethylaminopyridine method to give an ester 5 in 98% 
yield. Successive treatment of 5 with HCl in dioxane and coupling 
with Boc-amino acid by the DCC-HOBt method afforded a com- 
pound 6 in good yield. The OPac group of 6 was removed by 
Zn/AcOH, and then converted to the corresponding N- 
hydroxysuccinimide ester 7. After deblocking the Boc group of 7 with 
trifluoroacetic acid (TFA), the resultant active ester trifluoroacetate 
(8.TFA) was subjected to cyclization via peptide bond formation 
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A. Table II 
Physicochemical properties of the synthetic and natural products 
1 2 3 I4 5 6 7 
Ac-D-Phe-D-Leu-L-Phe-L-Thr-L-Val-L-Ala-(ba 
B. 
1 2 3 14 5 6 7j 
Ac-D-Phe-D-Leu-L-Phe-D-aThr-L-Val-L-Ala-(Z)-~ba 
Fig. 1. (A) Structure (I) proposed for A-3302-B (2) and/or TL-119 
(1). (B) Revised structure (II) proposed for 1 and/or 2. 
under high dilution conditions in pyridine (3 mM). Purification of 
the crude cyclization product by Sephadex LH-20 afforded a desired 
cyclic monomer (9) (M+: m/z 596.2694) in 21% yield. The tail part 
(10) of the precursor was prepared by the stepwise longation method 
as shown in Fig. 2. Fragment coupling by the DCC-HOBt method of 
the tail part 10 and the ring part 11 .HCI, which is derived from 9 by 
catalytic hydrogenation, and subsequent purification on Sephadex 
LH-20 column gave the stable precursor 4 in 67% yield. 
To convert the Thr residue of the precursor 4 into the AAba 
residue, dehydration of 4 was carried out by methanesulfonylation 
and subsequent &elimination. The methanesulfonyl (MS) group was 
introduced into 4 using MsCl (6 eq.) in pyridine at 0°C for 24 h to 
give the methanesulfonylated product (12) (S = 3.09: methyl protons 
of a MS group) in 80% yield. Subsequent reatment of 12 with 
diethylamine (2 eq.) in DMF at room temperature for 6 h afforded 
the desired peptide lactone 3 in 31% yield after decantation with 
MeOH and a mixture of DMF-EtOAc. Yields and physical constants 
of the synthetic intermediates are shown in Table I. The other syn- 
thetic intermediates were also characterized by elemental analysis 
and/or ‘H-NMR. The synthetic compound 3 gave a single spot on 
HPTLC using 3 solvent systems, satisfactory elemental analysis 
(Table II) and the expected molecular ion peak (Mf: m/z 803) by EI- 
MS analysis. 
Compound M.p. (“C) [C?]D/’ (DMSO) Rr’ Rr* Rr’ 
Natural 1 >250 -8.7 0.55 0.30 0.34 
Natural 2 289-294 (dec) -2.4 0.56 0.30 0.34 
Synthetic 3 277-293 (dec) -68.6 0.45 0.20 0.01 
HPTLC solvent systems; Rr’, CHC13-MeOH (9: 1, v/v); RS, 
CHCls-MeOH (15: 1, v/v); Rf3, EtOAc-EtOH (10: 1, v/v). Elemental 
analysis of 3; Found: C, 61.95; H, 7.12; N, 11.80. Calculated for 
C.QH~,O~N,. 1/2HzO: C, 62.05; H, 7.19; N, 12.06 
2.3. Antibacterial assay 
The antibacterial activity of both the natural and the synthetic 
compounds was evaluated by the usual agar dilution method, and the 
activity was expressed as minimum inhibitory concentration (MIC, 
pug/ml). 
3. RESULTS AND DISCUSSION 
In the synthesis of I we first focused on the synthesis 
of a stable precursor peptide, [L-Thr7]-I (4) containing 
a L-Thr residue in place of (Z)-AAba at position 7 in 3, 
because the Thr residue might be converted to (Z)- 
AAba residue by a dehydration reaction [4]. The com- 
pound 4 was successfully synthesized by the fragment 
coupling of the tail part 10 with the ring part 11. HCl 
as shown in Fig. 2. To convert the Thr residue of the 
precursor 4 into a AAba residue, dehydration of 4 was 
attempted by usual tosylation and subsequent p- 
elimination with base. However, the tosylation did not 
proceed perhaps because of the sterically hindered 
Table I 
Yields and physical constants of synthetic intermediates 
Compound % Yield Rra M.p. (“C) [cU]n2o/” Formula Found (a) 
(Calculated (070)) 
C H N 
4 67 0.64 (1) 275-277 - 56.3 (c 0.5, DMF) C42Hss,Or,,N,.HzO 59.90 7.31 11.61 
(60.06 7.32 11.67) 
5 98 0.82 (2) oil _ CXH~~CIONZ - 
6 74 0.76 (2) 72-74 + 8.6 (c 1, EtOAc) C~HseCi2N4 63.25 6.93 6.84 
(63.45 6.78 6.73) 
7 100 0.65 (1) oil _ GoHs301sNs 
8.TFA 100 0.10 (1) oil _ GsH45011N5.TFA 
9 21 0.69 (1) 90-95 -63.7 (c 1, EtOAc) Cd-IdhN~~H20 60.75 6.79 9.37 
(60.57 6.89 9.11) 
10 57 0.49 (3) 209-212 + 7.9 (c 1, DMF) C2eH&sN3 66.45 6.94 9.00 
(66.79 7.11 8.99) 
11’ HCI 98 0.23 (1) oil - C16&0&. HCl _ 
12 80 0.75 (1) 170-180 _ Cd%dd%S _ 
a Values in parentheses indicate TLC solvent systems; 1, CHCIs-MeOH (5 : 1, v/v); 2, CHCI,-MeOH (9 : 1, v/v); 
3, CHCIX-MeOH-AcOH (50:10:2, v/v). All the compounds except R.TFA, 9 and ll.HCI were also 
characterized by NMR 
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Fig. 2. Synthetic scheme for precursor 4 and 3. Fig. 3. CD spectra of synthetic 3 and natural 1 in trifluoroethanol. 
nature of 4 and/or p-toluenesulfonyl chloride. Then in- The IR spectra (KBr) of synthetic 3 and natural 1 
troduction of a less sterically hindered MS group to the suggested that both compounds are peptides containing 
hydroxyl function of 4 was attempted using MsCl in a lactone or an ester linkage: 3290 (N-H); 1660, 1640 
pyridine. The methanesulfonylated product 12 was ob- (amide I C=O); 1540 (amide II C=O); 1735 (synthetic) 
tained in satisfactory yield. Finally the desired peptide and 1725 cm-’ (natural) (ester or lactone C=O). 
lactone 3 was obtained by the treatment of 12 with However, the IR absorption bands of synthetic 3 in the 
diethylamine. The structure of synthetic 3 was confirm- fingerprint region (1500-650 cm-‘) showed small but 
ed by elemental analysis and by EI-MS. distinct differences from those of natural 1. 
Then the physicochemical properties of the synthetic 
3 and natural products, 1 and 2, were compared. Some 
of them are listed in Table II. However, both the 
melting point and the specific optical rotation of 3 were 
different from those reported for the natural ones. The 
behavior of 3 on HPTLC was also different from those 
of 1 or 2. But each of the natural products, 1 and 2, 
showed identical behavior on the HPTLC. Quantitative 
amino acid analysis of the acid hydrolysate of the syn- 
thetic and natural products reveal that all the products 
have the same amino acid constituents in identical 
ratios as shown in Table III. These results caused some 
doubts to arise concerning the proposed structure I for 
1 and/or 2. Therefore, the synthetic and natural pro- 
ducts were subjected to the following spectroscopic 
analyses. 
The ‘H-NMR spectra (90 MHz; DMSQ-de) of 3 and 
1 indicated the presence of a (Z)-AAba residue and an 
acetyl group in both compounds: r-CH3 protons and a 
vinyl proton on the side chain of the AAba residue (S = 
1.65 (3H, d, J = 7.2 Hz) and 6.75 ppm (lH, q, J = 
7.3 Hz) for 3, and 1.64 (3H, d, J = 7.3 Hz) and 
6.70 ppm (lH, q, J = 7.3 Hz) for 1, respectively) and 
CH3 protons in acetyl group (d = 1.72 ppm (3H), s) for 
3 and 1.78 ppm (3H, s) for 1). But some changes in the 
NMR spectral patterns of 3 and 1 were observed in the 
methyl and methylene region (O-2 ppm). 
Significant differences were observed in the CD spec- 
tra (Fig. 3) and the antimicrobial activities (Table IV) 
of synthetic and natural products, showing that 3 has 
a different backbone conformation from that of 1 in 
trifluoroethanol and no biological activity, whereas 
Table III 
Amino acid composition of acid hydrolysates of synthetic 3 and 
natural 1 and 2 
Amino acid 3 1 2 
Thr 0.99 (1) 0.98 (1) 1.15 (1) 
Ala 1.00 (1) 1.00 (1) 1.00 (1) 
Val 1.07 (1) 1.09 (1) 1.09 (1) 
Leu 0.93 (1) 1.00 (1) 0.98 (1) 
Phe 2.02 (2) 2.20 (2) 2.11 (2) 
NH, 1.38 (1) 1.12 (1) 0.65 (1) 
Table IV 
Antibacterial activity of the synthetic and natural products 
Strain Synthetic Natural 
3 1 2 
Bacillus subtilis PC1 219 >50 12.5 12.5 
Staphylococcus aureus FAD 209 JC-1 >50 1.6 1.6 
Escherichiu coli NIHJ JC-2 >50 >50 >50 
Klebsiella pneumoniae >50 >50 >50 
The values are MIC bg/ml). 
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Appendix 
Physical constants of synthetic intermediates 
Compound M.p. (“C) [a]n*O/” Formula Found (a) 
(Calculated (70)) 
C H N 
Z-L-Thr-OPac 126-129 -22.1 (c 1, MeOH) CzoH2106Ni 64.66 5.81 3.81 
(64.88 5.70 3.77) 
Z-L-Thr[Boc-L-Ala-L-Thr(Bzl)-]-OPaca oil C39H47011N3 
Z-L-Thr[Boc-L-Val-L-Ala-L-Thr(Bzl)-]-OH 84 + 15.9 (c 1, EtOAc) Cs6HsoOiiN4 60.40 7.14 7.97 
(60.49 7.05 7.84) 
Boc-D-Leu-L-Phe-OH oil CzoHsoOsNz 
HCl . H-D-Leu-L-Phe-OH 183-188 - 16.6 (c 1, MeOH) C,rHz20sNa. HCl . 56.76 7.51 8.64 
1/5HzO (56.58 7.41 8.80) 
Boc-D-Phe-D-Leu-L-Phe-OH 164-166 +24.4 (c 1, MeOH) Cr9HsaOe.Ns. Hz0 64.02 7.38 7.80 
(64.07 7.60 7.73) 
HCl . H-D-Phe-D-Leu-L-Phe-OH 224-227 + 15.6 (c 1, MeOH) CtlHs104Nr.HCl 62.20 6.94 9.08 
(62.34 6.98 9.10) 
a Satisfactory NMR data were obtained 
natural 1 and 2 exhibited strong inhibitory activities 
against Gram-positive bacteria. 
However, synthetic 3 gave an almost identical EI- 
mass spectrum to that of natural 1: a molecular ion 
peak at m/z 803 and major fragment ion peaks at m/z 
703, 632, 614, 533, 450, 303, 190 and 162. The 
fragmentation pattern in the mass spectrum of 3 sup- 
ported that synthetic 3 has the same structure I except 
for the stereochemistry of that proposed for 1 and/or 
2 ~31. 
The above results imply that the differences between 
the synthetic and natural products in their 
physicochemical and biological properties except for 
the mass spectra might be brought about by their con- 
formational differences possibly caused by the presence 
of some amino acid residues with a different configura- 
tion. Therefore, re-examination of the configuration of 
the constituent amino acid residues in natural products 
seemed to be necessary. The configuration of the con- 
stituent amino acids in natural 1 and 2 was determined 
by the modified Manning-Moore method [5]. Coupling 
of acid hydrolysate of 1 with Z-L-Leu-OSu and subse- 
quent hydrogenolysis gave a mixture of dipeptides (L- 
Leu-amino acid), which was analyzed by an amino acid 
analyzer. The results of the chromatogram indicate the 
presence of L-Ala, L-Val, D-Leu, L-Phe and D-Phe in 
1 and 2 as reported before [3] (data not shown). The ex- 
pected L- or D-Thr could not be detected, however, the 
presence of D-aThr in 1 and 2 was confirmed. cy- 
Aminobutyric acid (Aba) was also detected in the acid 
hydrolysate of hydrogenated material of natural 1. 
From all of the results obtained and other reports 
[2,3], we tentatively propose a revised structure (II) for 
natural TL-119 (1) and/or A-3302-B (2), which con- 
tains a D-aThr residue in place of the original L-Thr 
residue at position 4, as shown in Fig. 1B. It may be 
that A-3302-A [3] (which is different from A-3302-B in 
that it has a propionyl group instead of an acetyl group 
at the N-terminus) also contains a D-aThr in the cyclic 
part. It is also noteworthy that many cyclic peptides 
isolated from microorganisms have a D-amino acid 
residue in the cyclic part. Further confirmation of the 
revised structure II for 1 and/or 2 by its chemical syn- 
thesis is now in progress. 
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